Agostino Consoli

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Bariatric Surgery

Clinical Practice

Top Venues

Diabetes/metabolism research and reviews

Journal of clinical medicine

Oxidative medicine and cellular longevity

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli, Gloria Formoso
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of clinical medicine 13 (11) (2024)
Maria Pompea Antonia Baldassarre, Giulia Di Dalmazi, Sara Coluzzi, Federica Carrieri, Fabrizio Febo, Giorgia Centorame, Piergiuseppe Cassino, Luigi Piacentino, Marco Giorgio Baroni, Agostino Consoli, Gloria Formoso
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment. Journal of clinical medicine 13 (11) (2024)
Gian Poalo Fadini, Enrico Longato, Mario Luca Morieri, Enzo Bonora, Agostino Consoli, Bruno Fattor, Mauro Rigato, Federica Turchi, Stephano Del Prato, Angelo Avogaro, Anna Solini, null null
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care. Diabetologia (2024)
Agostino Consoli, Gloria Formoso
Patient perceptions of insulin therapy in diabetes self-management with insulin injection devices. Acta diabetologica (2023)
Maria Pompea Antonia Baldassarre, Caterina Pipino, Assunta Pandolfi, Agostino Consoli, Natalia Di Pietro, Gloria Formoso
Old and New Biomarkers Associated with Endothelial Dysfunction in Chronic Hyperglycemia. Oxidative medicine and cellular longevity 2021 (2021)
Agostino Consoli, Leszek Czupryniak, Rui Duarte, György Jermendy, Alexandra Kautzky-Willer, Chantal Mathieu, Miguel Melo, Lawrence A Leiter, Frank Nobels, Nikoloas Papanas, Gabriela Roman, Oliver Schnell, Alexis Sotiropoulos, Coen D A Stehouwer, Cornelis Cees J Tack, Vincent Woo, Gian Poalo Fadini, Itamar Raz
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel. Diabetes, obesity & metabolism 22 (10) (2020)
Mario Luca Morieri, Agostino Consoli, Giorgio Sesti, Francesco Purrello, Angelo Avogaro, Gian Poalo Fadini, null null
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world. Diabetes/metabolism research and reviews 37 (1) (2020)
Francesca Santilli, Francesco Zaccardi, Rossella Liani, Giovanna Petrucci, Paola Simeone, Dario Pitocco, Romina Tripaldi, Alessandro Rizzi, Gloria Formoso, Alfredo Pontecorvi, Ermanno Angelucci, Francesca Pagliaccia, Maria Golato, Francesca De Leva, Ester Vitacolonna, Bianca Rocca, Agostino Consoli, Carlo Patrono
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance. Diabetes/metabolism research and reviews 36 (2) (2019)
Gloria Formoso, Maria Pompea Antonia Baldassarre, Federica Ginestra, Maria Assunta Carlucci, Ines Bucci, Agostino Consoli
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. Diabetes/metabolism research and reviews 35 (5) (2019)
Raffaella Gentilella, Valeria Pechtner, Antonella Corcos, Agostino Consoli
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same? Diabetes/metabolism research and reviews 35 (1) (2018)